Zurex Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZUREX PHARMA, and when can generic versions of ZUREX PHARMA drugs launch?
ZUREX PHARMA has one approved drug.
There are seven US patents protecting ZUREX PHARMA drugs.
There are fifty-seven patent family members on ZUREX PHARMA drugs in twenty-two countries and eight supplementary protection certificates in six countries.
Drugs and US Patents for Zurex Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zurex Pharma | ZURAGARD | isopropyl alcohol | SOLUTION;TOPICAL | 210872-001 | Apr 26, 2019 | OTC | Yes | Yes | 9,011,897 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Zurex Pharma | ZURAGARD | isopropyl alcohol | SOLUTION;TOPICAL | 210872-001 | Apr 26, 2019 | OTC | Yes | Yes | 8,389,583 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Zurex Pharma | ZURAGARD | isopropyl alcohol | SOLUTION;TOPICAL | 210872-001 | Apr 26, 2019 | OTC | Yes | Yes | 8,226,971 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Zurex Pharma | ZURAGARD | isopropyl alcohol | SOLUTION;TOPICAL | 210872-001 | Apr 26, 2019 | OTC | Yes | Yes | 8,703,828 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Zurex Pharma | ZURAGARD | isopropyl alcohol | SOLUTION;TOPICAL | 210872-001 | Apr 26, 2019 | OTC | Yes | Yes | 9,844,654 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Zurex Pharma | ZURAGARD | isopropyl alcohol | SOLUTION;TOPICAL | 210872-001 | Apr 26, 2019 | OTC | Yes | Yes | 10,688,291 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Zurex Pharma Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Israel | 185120 | ⤷ Try a Trial |
Mexico | 2019008119 | ⤷ Try a Trial |
Hong Kong | 1223860 | ⤷ Try a Trial |
European Patent Office | 2986333 | ⤷ Try a Trial |
Slovenia | 1688154 | ⤷ Try a Trial |
Spain | 2623909 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Zurex Pharma Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1448186 | 2012C/051 | Belgium | ⤷ Try a Trial | PRODUCT NAME: MELANGE DE CATECHOLS ISOLES D'UN EXTRAIT DE THE (CAMELLIA SINENSIS (L.) O. KUNTZE) AVEC DU MYRISTATE D'ISOPROPYLE; AUTHORISATION NUMBER AND DATE: BE424383 20120719 |
0289349 | SPC/GB04/007 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: ISOPROPYL(+)-(Z)-7-((1R,2R,3R,5S)-3,5-DIHYDROXY-2-(3-OXODECYL)CYCLOPENTYL)-5-HEPTENOATE; REGISTERED: CH 55634 01 20010329; UK PL00101/0667 20031112 |
1448186 | 29/2010 | Austria | ⤷ Try a Trial | PRODUCT NAME: "(-)-EPIGALLOCATECHIN GALLAT MIT ISOPROPYLMYRISTAT"; NAT. REGISTRATION NO/DATE: 1-29000 20100217; FIRST REGISTRATION: DE 73486.00.00 (MITTEILUNG) 20090908 |
2203462 | 2014029 | Norway | ⤷ Try a Trial | PRODUCT NAME: SOFOSBUVIR. (S)-ISOPROPYL 2-; NAT. REG. NO/DATE: EU/1/13/894 20140116; FIRST REG. NO/DATE: (001-002) 20140117 |
0364417 | SPC/GB97/014 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: LATANOPROST (I.E. 13,14-DIHYDRO-17-PHENYL-18,19,20-TRINOR-PGF-ALPHA-ISOPROPYLESTER); NAT. REGISTRATION NO/DATE: 00032/0220 19961216; FIRST REGISTRATION: SE 12716 19960718; SPC EXTENSION AUTHORISATION: PL00057/1057-008 20101216 |
1448186 | C300550 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: MENGSEL VAN CATECHOLEN GEISOLEERD UIT EEN EXTRACT VAN GROENE THEE, CAMELLIA SINENSIS, L. O. KUNTZE MET ISOPROPYLMYRISTAAT; NATL. REGISTRATION NO/DATE: RVG 110904 20120920; FIRST REGISTRATION: DE 73486.00.00 20090831 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.